0 A peek behind the paper – Dr Shabana on quorum quenching
Take a look behind the scenes of a recent Future Microbiology review as we ask the authors about quorum quenching and using nanoparticles as antibiotics.
Browsing: Basic > Drug Development
0 Could gene therapy be an effective treatment for chlamydia?
New research has developed a nanoparticle formulation that can knock down a key chlamydia binding protein and simultaneously induce autophagy – showing promise against this infection.
0 New treatments for onchocerciasis – the current clinical pipeline
Some of the challenges with mass ivermectin administration could be addressed with new drugs or drug combinations with higher effect for the parasite – leading us to ask, what new treatments are currently in the clinical pipeline?
0 Takeda’s dengue vaccine meets primary endpoint in Phase III: January’s industry headlines
Take a look at this month’s industry headlines including an FDA approval for a vaccine protecting against six diseases, positive clinical trial results for bacteraemia and dengue vaccines and new funding for CRSIPR-based antimicrobials.
0 Antibiotic development: UK announces new incentives for pharma companies
The UK government has published a 20-year vision and a 5-year national action plan for how the UK will contribute to controlling and containing antimicrobial resistance by 2040.
0 New partnerships for antibiotic discovery and further cuts in the field: December’s industry headlines
Take a look at this month’s industry headlines including a new partnership for antibiotic development, approval for HIV drugs and authorization for a cytomegalovirus test.
0 Lysis vs lysogeny: phages tap into quorum-sensing as control mechanism
A bacteriophage, VP882, has been identified to use bacterial quorum-sensing as a method to control the lysis-lysogeny decision. This is the first time a virus has been shown to detect a bacterial molecule.
1 A peek behind the paper – Hessel van der Weide on antibiotic-nanomedicines
Take a look behind the scenes of a recent Future Microbiology paper as we ask the authors about the challenges in treating respiratory tract infections and how nanomedicines could help.
0 Prion pathogenesis – how do prions reach the brain?
New research has suggested that the spread of prions to the brain does not occur via the blood–brain barrier, implicating other mechanisms.
0 Merck cuts back on rotavirus vaccine commitment to West Africa: November’s industry headlines
Positive results for zoliflodacin, EMA approval for fexinidazole and Merck cuts rotavirus commitment – take a look a the month’s industry headlines.
